Pharming NV has paid €17.9m upfront to Novartis AG for an exclusive license to CDZ173, a late stage drug for...
Up To Date
Latest News
Researchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem...
Bayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem...
Using a platform tailored to patients’ specific cancer mutations, British and US researchers for the first...
Novo Holdings A/S (Novo Holdings) invests $72m in LanzaTech to support development of the company’s...
German researchers have developed a software that allows to manage and correct the huge amount of data...